The role of basal insulin in type 2 diabetes management
Brunton, S.A.; White, J.R.; Renda, S.M.
Journal of Family Practice Suppl: S1-S8
2005
ISSN/ISBN: 0094-3509 PMID: 16271258 Document Number: 592213
Document emailed within 1 workday
Related Documents
Ghosal, S.; Sinha, B.; Majumder, A.; Das, A.Kumar.; Singh, A.Kumar.; Ghoshdastidar, B.; Maji, D.; Goyal, G.; Mukherjee, J.Jyoti.; Gangopadhyay, K.Kumar.; John, M.; Chatterjee, S.; Jaggi, S.; Ray, S.; Majumdar, S.; Sharma, S.Kumar. 2017: Consensus on "Basal insulin in the management of Type 2 Diabetes: Which, When and How?" Journal of the Association of Physicians of India 65(7): 51-62Kalra, S.; Gupta, Y. 2016: A patient centred approach to basal insulin choice for the management of type 2 diabetes mellitus Jpma. Journal of the Pakistan Medical Association 66(3): 360-361
Bu, S.; Guo, X.-H.; Yang, W.-Y.; Lu, G.-Z.; Yang, Z.-J.; Ren, T.-T.; Gao, Y. 2007: Post-hoc analyses of type 2 diabetes patients switch from premixed insulin regimen to basal insulin plus oral hypoglycemic agents regimen Zhonghua Yi Xue Za Zhi 87(44): 3115-3118
Holman, R.R.; Steemson, J.; Turner, R.C. 1987: Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement Diabetic Medicine: a Journal of the British Diabetic Association 4(5): 457-462
Scheen, A.é J.; Paquot, N. 2014: Potential of a GLP-1 receptor agonist combined with basal insulin in the treatment of type 2 diabetes Revue Medicale Suisse 10(439): 1549-1554
Shubrook, J.H. 2018: Advances in Type 2 Diabetes: Focus on Basal Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy Journal of Family Practice 67(8 Suppl): S49-S54
Kuritzky, L. 2006: Addition of basal insulin to oral antidiabetic agents: a goal-directed approach to type 2 diabetes therapy Medgenmed: Medscape General Medicine 8(4): 34
Sumník, Z.; Venhácová, J.; Brázdová, L.; Skvor, J. 2008: Long-term improvement of fasting glycaemia after switching basal insulin from NPH to determir in children with type 1 diabetes: a 1-year multicentre study Casopis Lekaru Ceskych 147(8): 421-425
Balabolkin, M.I.; Klebanova, E.M. 2003: Role of insulin resistance in pathogenesis of type 2 diabetes Terapevticheskii Arkhiv 75(1): 72-77
Usui, I.; Tobe, K. 2011: The role of inflammation in the development of insulin resistance in type 2 diabetes Nihon Rinsho. Japanese Journal of Clinical Medicine 69(3): 555-562
Chen, X.; Su, M.; Wang, C.; Wu, Z.; Li, S.; Ying, X.; Wei, G.; Fu, C.; Jiang, Q. 2015: Role of insulin resistance and β cell function in the development of newly diagnosed type 2 diabetes Wei Sheng Yan Jiu 44(6): 881-886
Wadström, J.; Gannedahl, G.; Wahlberg, J.; Frödin, L.; Tedbrandt, A.; Berne, C. 1994: Development of type Ii diabetes after combined kidney-pancreas transplantation in a patient with type i (insulin-dependent) diabetes Transplantation Proceedings 26(3): 1761-1762
Fernández Landó, L.; Massari, F.; Oviedo, A.; Jiang, H. 2012: Starting an insulin regimen with insulin lispro mix 25 versus glargine insulin for type 2 diabetes Medicina 72(3): 235-242
LeRoith, D. 2002: Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities American Journal of Medicine 113(Suppl): 3s
Rattarasarn, C.; Thamprasit, A.; Leelawattana, R.; Soonthornpun, S.; Setasuban, W. 2001: The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus Journal of the Medical Association of Thailand 84(12): 1754-1762
Philips, J-Christophe.; Paquot, N.; Scheen, A.J. 2019: Potential role of SGLT2 inhibitors in the management of type 1 diabetes Revue Medicale Suisse 15(659): 1426-1430
Unger, J.; Nadeau, D.A. 2007: Defining the role of incretin mimetic therapy in the management of type 2 diabetes Journal of Family Practice 56(12 Suppl New): S4
Shpakov, A.O. 2014: The role of alterations in the brain signaling systems regulated by insulin, IGF-1 and leptin in the transition of impaired glucose tolerance to overt type 2 diabetes mellitus Tsitologiia 56(11): 789-799
Dunicheva, M.; Zagorovskaya, T.; Patrakeeva, E. 2018: The Role of Psychological Features in Management of Patients with Type 1 Diabetes (Case Report) Georgian Medical News 2018(277): 67-70
Kalra, S. 2011: Emerging role of dipeptidyl peptidase-IV (DPP-4) inhibitor vildagliptin in the management of type 2 diabetes Journal of the Association of Physicians of India 59: 237-245